SCHEMBL7707829

SCHEMBL7707829

COC(=O)C1=Cc2c(c3c(n2Cc2cc4c(cc2Cl)OCO4)C(=O)CCC3)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HPGD P15428 2/20 0.35
SLC22A12 Q96S37 1/20 0.34
MAPK1 P28482 3/20 0.32
HSD17B10 Q99714 3/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
MCHR1 Q99705 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK10 P53779 1/20 0.32
HIF1A Q16665 1/20 0.32
OPRM1 P35372 2/20 0.31
OPRK1 P41145 2/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRL1 P41146 1/20 0.31
HTT P42858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420612 0.78 ALDH1A1 (0.44) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7707827 0.74 KDM4E (0.33) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7474496 0.74 MEN1 (0.43) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7426960 0.70 ALDH1A1 (0.51) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7421878 0.69 KDM4E (0.41) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7473906 0.65 ALDH1A1 (0.43) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7476678 0.65 SLC22A12 (0.39) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12
SCHEMBL7371677 0.63 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2HPGDMAPK1
SCHEMBL7422984 0.62 DPP4 (0.47) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL6305977 0.62 ALDH1A1 (0.41) KDM4EALDH1A1SMN1; SMN2HPGDSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed